1. |
Details of person discharging managerial responsibilities/person closely associated with them |
a) |
Name |
Anita Hyman |
2. |
Reason for the notification |
a) |
Position / status |
Person Closely Associated with Harry Hyman (Director of BioPharma Credit PLC) |
b) |
Initial notification / amendment |
Initial notification |
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
BioPharma Credit PLC |
b) |
LEI |
213800AV55PYXAS7SY24 |
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument Identification Code |
Ordinary Shares of $0.01 each GB00BDGKMY29 |
b) |
Nature of the transaction |
Purchase of Shares (acquired as part of dividend reinvestment) |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
£0.8436 |
35 |
|
d) |
Aggregated information - Aggregated volume - Price |
N/A |
e) |
Date of the transaction |
10.07.19 |
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|
|
|
|